Compare AFL & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFL | AME |
|---|---|---|
| Founded | 1955 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8B | 47.9B |
| IPO Year | 1994 | 1998 |
| Metric | AFL | AME |
|---|---|---|
| Price | $113.83 | $230.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $110.18 | ★ $233.27 |
| AVG Volume (30 Days) | ★ 2.0M | 1.0M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.16% | 0.59% |
| EPS Growth | N/A | ★ 7.93 |
| EPS | ★ 6.82 | 6.40 |
| Revenue | ★ $17,164,000,000.00 | $7,401,116,000.00 |
| Revenue This Year | N/A | $8.88 |
| Revenue Next Year | $1.61 | $5.57 |
| P/E Ratio | ★ $16.58 | $35.99 |
| Revenue Growth | N/A | ★ 6.63 |
| 52 Week Low | $96.95 | $153.73 |
| 52 Week High | $119.32 | $242.05 |
| Indicator | AFL | AME |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 58.81 |
| Support Level | $106.07 | $225.97 |
| Resistance Level | $115.84 | $241.00 |
| Average True Range (ATR) | 2.08 | 4.89 |
| MACD | 0.54 | 1.92 |
| Stochastic Oscillator | 97.75 | 78.83 |
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.